title: TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF.
abstract: The aim of this work was to study the relative role of the two TNF receptors (p55 and p75) in the central actions of TNF, studying the elevation of serum corticosterone (CS) and IL-6 levels after injection of recombinant murine (rm)TNF (intracerebroventricularly (i.c.v.)) in normal or p55-deficient (p55 -/-) mice. rmTNF induced high serum IL-6 levels and doubled serum CS in normal mice, whereas no elevation of serum IL-6 or CS was induced in p55 -/- mice. However, a normal CS response was observed in p55 -/- mice after LPS (2.5 microg, i.c.v.). p55 -/- mice also responded, although to a lesser extent than p55 +/+, in terms of LPS-induced IL-6 production. We also injected two agonist Abs specific for the two receptors, alpha p55 and alpha p75. While alpha p55 injected i.c.v. induced a marked elevation in CS and IL-6, alpha p75 induced CS (although less than alpha p55) but no IL-6. rmTNF, which binds both receptors, was more potent in inducing IL-6 and CS than injection of rhTNF, which in mice binds only p55. Finally, we investigated the role of p55 and p75 in IL-6 induction by TNF in a murine brain endothelioma. The results resembled closely those obtained in vivo: rmTNF was more potent than rhTNF and only alpha p55, and not alpha p75, induced IL-6 production. These data indicate that p55 plays a major role in TNF activation of the hypothalamus-pituitary-adrenal axis and in the centrally mediated induction of peripheral IL-6 by TNF, but p75, despite having little IL-6 inductive properties by itself, seems to potentiate p55 induction of IL-6.
authors.affiliation: Mario Negri Institute for Pharmacological Research, Milan, Italy.
authors.forename: F
authors.initials: F
authors.lastname: Benigni
authors.forename: R
authors.initials: R
authors.lastname: Faggioni
authors.forename: M
authors.initials: M
authors.lastname: Sironi
authors.forename: G
authors.initials: G
authors.lastname: Fantuzzi
authors.forename: P
authors.initials: P
authors.lastname: Vandenabeele
authors.forename: N
authors.initials: N
authors.lastname: Takahashi
authors.forename: S
authors.initials: S
authors.lastname: Sacco
authors.forename: W
authors.initials: W
authors.lastname: Fiers
authors.forename: W A
authors.initials: WA
authors.lastname: Buurman
authors.forename: P
authors.initials: P
authors.lastname: Ghezzi
mesh_terms: D000818:Animals; D001812:Blood-Brain Barrier; D002478:Cells, Cultured; D002552:Cerebral Ventricles; D003345:Corticosterone / Q000097:blood*; D004730:Endothelium, Vascular / Q000378:metabolism; D006801:Humans; D015850:Interleukin-6 / Q000097:blood*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology*; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage*
chemical_list: D015850:Interleukin-6; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D003345:Corticosterone